sumatriptan has been researched along with Peripheral Nervous System Diseases in 1 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
Peripheral Nervous System Diseases: Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sumatriptan, which is an anti-migraine agent is a specific agonist for 5-hydroxytryptamine 1B, 1D (5HT1B, 1D) receptors." | 1.48 | The protective effects of sumatriptan on vincristine - induced peripheral neuropathy in a rat model. ( Abdollahi, A; Afshari, K; Dehpour, AR; Hadian, MR; Khalilzadeh, M; Momeny, M; Norouzi-Javidan, A; Panahi, G; Rahimi, N; Rashidian, A; Shakiba, S, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khalilzadeh, M | 1 |
| Panahi, G | 1 |
| Rashidian, A | 1 |
| Hadian, MR | 1 |
| Abdollahi, A | 1 |
| Afshari, K | 1 |
| Shakiba, S | 1 |
| Norouzi-Javidan, A | 1 |
| Rahimi, N | 1 |
| Momeny, M | 1 |
| Dehpour, AR | 1 |
1 other study available for sumatriptan and Peripheral Nervous System Diseases
| Article | Year |
|---|---|
The protective effects of sumatriptan on vincristine - induced peripheral neuropathy in a rat model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Male; Neuroprotective Agents; Pa | 2018 |